Correlation Between Milestone Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Milestone Pharmaceuticals and Blueprint Medicines
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Milestone and Blueprint is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 1.36 times more return on investment than Blueprint Medicines. However, Milestone Pharmaceuticals is 1.36 times more volatile than Blueprint Medicines Corp. It trades about 0.28 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.21 per unit of risk. If you would invest 144.00 in Milestone Pharmaceuticals on August 26, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Blueprint Medicines Corp |
Milestone Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Milestone Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.The idea behind Milestone Pharmaceuticals and Blueprint Medicines Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |